CHICAGO -- Germline variations did not predict the risk of taxane-induced peripheral neuropathy (TIPN) in a phase II trial ...

The form will remain open until noon on June 12, when, Sztajn wrote, the collected questions will be submitted to university ...

Noticing a mysterious spot on your skin can trigger an anxiety-inducing mental debate: Is it just a harmless growth or ...

June 4, 2024 — Researchers have developed a simpler and more effective screening method for cervical cancer than the method used today. A comprehensive study shows that the test detects ...

There’s no time like the present to tackle an endeavor that you’ve been postponing until the “right” moment came along. With the responsive moon grooving through your sign, you feel like ...

In the HERCULES trial, pembrolizumab with platinum-based therapy showed promising safety and efficacy in the treatment of ...

Lung cancer occurs when cells in the lungs divide uncontrollably, causing tumors to grow. Anyone can develop lung cancer, but cigarette smoking and exposure to smoke, inhaled chemicals, or other ...

Denise (Dee) Casapulla, 54, knows just how much work it takes to keep a household running. Whether it’s staying on top of tasks such as cleaning and grocery shopping, overseeing the kids ...

An analysis that overviewed dermatologic mobile apps with artificial intelligence (AI) features led researchers to voice ...

An eGFR cutoff of 75 mL/min/1.73 m2 after 1 year of treatment was predictive of progression to chronic kidney disease among patients with lupus nephritis.

In part 2 of our 3-part series, antibody-drug conjugates like enfortumab vedotin and tisotumab vedotin offer novel options ...

New data from the completed dose escalation part and ongoing expansion part of Study 1100, an ongoing US Phase 1 study evaluating NBTXR3 followed by anti-PD-1 in patients with recurrent ...